Investments
Regeneron, Sanofi Soar On Blow-Out Results In ‘Smoker’s Lung’
Sanofi (SNY) and Regeneron Pharmaceuticals‘ (REGN) asthma drug Dupixent succeeded in a final-phase study of patients with “smoker’s lung,” leading SNY stock and REGN stock to rocket Thursday. In the Phase 3 study, Dupixent led […]